Stay updated on Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The MAGIC-8 study record is now available, describing a completed trial of nivolumab with or without BMS-986253 and intermittent androgen-deprivation therapy for hormone-sensitive prostate cancer. The record includes study design, participant criteria, locations, outcome measures, and a study protocol document.
    Difference
    58%
    Check dated 2026-11-08T15:00:13.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:53:05.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes during a transition appears above the ClinicalTrials.gov 403 error page.
    Difference
    1%
    Check dated 2026-10-25T15:53:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T22:26:06.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T22:25:20.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, indicating access is blocked while the site header and footer remain visible.
    Difference
    20%
    Check dated 2026-09-20T20:36:09.000Z thumbnail image

Stay in the know with updates to Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.